When it comes to women’s healthcare and the Federal Drug Administration, there are a number of misconceptions and myths floating around. Given the FDA’s immense agency in the world of women’s health, it’s only natural that some questions and concerns would arise. Today, the experts from Ogeechee OB-GYN in Statesboro, GA will debunk three common myths about women and this administration.

Myth: The FDA Doesn’t Account For Sex Differences

While many of the same diseases afflict both sexes, they often affect men and women differently. To account for this, the FDA has required companies to provide information comparing the effects of their drugs on both men and women since 1998. Now, any discrepancies in safety, side effects, and more, will be listed in your medication’s labeling and drug trials. These effects will continued to be monitored after the drug has spent some time on the market. 

Myth: Women Are Not Included In Clinical Trials

Although it wasn’t always the case, today both men and women are included in clinical trials. Since 1987, the FDA has mandated that drug testing involving animals incorporate both female and male subjects. The FDA also continually monitors the inclusion and participation of women in clinical trials, although the FDA itself never conducts such tests.

Myth: The FDA Can Control A Drug’s Market Price

The FDA only possesses the power to approve or deny a product, but cannot play a role in its price—that is up to the company. Unfortunately, this is why we sometimes see inexpensive products priced well above market value, such as the instance of Daraprim, or more recently the EpiPen. This practice has largely been deemed unethical. 

For women’s healthcare in Statesboro you can rely on, look no further than Ogeechee OB-GYN. From prenatal care to gynecology services, the health clinic offers every service women need to live healthily and well. To schedule an appointment, call today at (912) 871-6206, and for more information, visit the practice’s website.